Market Research Logo

Clinical Oncology Next-generation Sequencing Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Clinical Oncology Next-generation Sequencing Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

FMI has conducted a study on the clinical oncology next-generation sequencing through the analysis and forecast of the clinical oncology next-generation sequencing market in its publication titled ‘Clinical Oncology Next-Generation Sequencing Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.’ This report on the clinical oncology next-generation sequencing market covers the various key factors influencing the demand and supply of clinical oncology next-generation sequencing over the next several years. This report consists of the drivers, restraints, various market trends, and opportunities for participants in the clinical oncology next-generation sequencing market.

A study has been done on the various technologies of next-generation sequencing and how each technology differs from other technologies. The report consists of the ongoing trends in the market, and the various opportunities for the significant growth of the clinical oncology next-generation sequencing market.

The report consists of the various strategies adopted by the key manufacturers in the clinical oncology next-generation sequencing market. International collaborations are one of the main strategies adopted by the key manufacturers in the market. Nowadays, manufacturers are trying to develop new error-free sequencing technologies to obtain better sequencing results.

The report also focuses on the various macro-economic factors that are affecting the overall growth of the market. Some of the important macro-economic factors affecting the growth of the market include economic growth & inflation, and growing biomedical research in emerging markets. Changing biomedical and biotechnological demographics in emerging economies, such as China, India, Brazil, and South Africa, are expected to fuel the growth opportunities for medical device manufacturers. Public as well as private healthcare expenditure in these countries is expected to witness high growth, which is, in turn, expected to attract the manufacturers in these markets.

The report also contains key regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa. Various trends in these regions have been covered in this report. The market attractiveness index of the products for all the regions have been covered in this report. The report also contains the market scenario of the different countries covered by each region.

The report also contains the forecast factors that impact the growth of the market. There forecast factors are expected to increase the growth of the clinical oncology next-generation sequencing market. The impact analysis of the forecast factors has been covered in the report.

The regulatory scenario for the next-generation sequencing used for oncology has been covered in this report. The profiles of various companies associated with the clinical oncology next-generation treatment market has also been included in this report, in addition to the competition landscape of various key players in the clinical oncology next-generation sequencing market.

Various key players in the clinical oncology next-generation sequencing market manufacturer several products for the sequencing of DNA. The strengths and weakness of various companies have been covered in the report.

The report also focuses on the research methodology being adopted by researchers for the estimation of the clinical oncology next-generation sequencing market in different geographies.

Global Clinical Oncology Next-Generation Sequencing Market: Segmentation

Clinical Oncology Next-Generation Sequencing Market Analysis by Product Type

Sequencing Platforms

Sequencing Products

Kits and Reagents

Services

Clinical Oncology Next-Generation Sequencing Market Analysis by Technology

Ion Semiconductor Sequencing

Pyro-Sequencing

Synthesis Sequencing (SBS)

Real Time Sequencing (SMRT)

Ligation Sequencing

Reversible Dye Termination Sequencing

Nano-Pore Sequencing

Clinical Oncology Next-Generation Sequencing Market Analysis by Application

Whole Tumor Genome Sequencing

Whole Tumor Exome Sequencing

Targeted Tumor Genome Profiling

Tumor Transcriptome Sequencing

Tumor-normal Comparisons

Others

Clinical Oncology Next-Generation Sequencing Market Analysis by End User

Hospital Laboratories

Clinical Research Organizations

Diagnostic Laboratories

Others

Clinical Oncology Next-Generation Sequencing Market Analysis by Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East & Africa


1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.2. Forecast Factors - Relevance & Impact
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Trends
4. Key Success Factors
4.1. Cancer Epidemiology, By Region
4.2. Key Regulations
5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Value (US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Component
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Component, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Component, 2019-2029
6.3.1. Sequencing Platforms
6.3.2. Sequencing Products
6.3.3. Kits and Reagents
6.3.4. Services
6.4. Market Attractiveness Analysis By Component
7. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Technology
7.1. Introduction
7.2. Historical Market Size (US$ Mn) and Volume Analysis By Technology, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2018 - 2018
7.3.1. Ion Semiconductor Sequencing
7.3.2. Pyro-Sequencing
7.3.3. Synthesis Sequencing (SBS)
7.3.4. Real Time Sequencing (SMRT)
7.3.5. Ligation Sequencing
7.3.6. Reversible Dye Termination Sequencing
7.3.7. Nano-Pore Sequencing
7.3.8. Others
7.4. Market Attractiveness Analysis By Application
8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Application
8.1. Introduction
8.2. Historical Market Size (US$ Mn) By Application, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2018 - 2018
8.3.1. Whole Tumor Genome Sequencing
8.3.2. Whole Tumor Exome Sequencing
8.3.3. Targeted Tumor Genome Profiling
8.3.4. Tumor Transcriptome Sequencing
8.3.5. Tumor-normal Comparisons
8.3.6. Others
8.4. Market Attractiveness Analysis By Application
9. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by End User
9.1. Introduction
9.2. Historical Market Size (US$ Mn) By End User, 2014-2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2018 - 2018
9.3.1. Hospital Laboratories
9.3.2. Clinical Research Organizations
9.3.3. Diagnostic Laboratories
9.3.4. Others
9.4. Market Attractiveness Analysis By End User
10. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. MEA
10.4. Market Attractiveness Analysis By Region
11. North America Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Component
11.3.3. By Technology
11.3.4. By Application
11.3.5. By End User
11.4. Market Attractiveness Analysis
12. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Component
12.3.3. By Technology
12.3.4. By Application
12.3.5. By End User
12.4. Market Attractiveness Analysis
13. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Component
13.3.3. By Technology
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
14. East Asia Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
14.3.1. By Country
14.3.1.1. C China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Component
14.3.3. By Technology
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
15. South Asia Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Component
15.3.3. By Technology
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
16. Oceania Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Component
16.3.3. By Technology
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
17. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Component
17.3.3. By Technology
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
18. Emerging Countries Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis
18.2.1. Introduction
18.2.2. Market Value Proportion Analysis by Market Taxonomy
18.2.2.1. By Component
18.2.2.2. By Technology
18.2.2.3. By Application
18.2.2.4. By End User
18.3. South Korea Clinical Oncology Next Generation Sequencing (NGS) Market Analysis
18.3.1. Introduction
18.3.2. Market Value Proportion Analysis by Market Taxonomy
18.3.2.1. By Component
18.3.2.2. By Technology
18.3.2.3. By Application
18.3.2.4. By End User
18.4. India Clinical Oncology Next Generation Sequencing (NGS) Market Analysis
18.4.1. Introduction
18.4.2. Market Value Proportion Analysis by Market Taxonomy
18.4.2.1. By Component
18.4.2.2. By Technology
18.4.2.3. By Application
18.4.2.4. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Illumina, Inc.
20.2.1.1. Overview
20.2.1.2. Product Portfolio
20.2.1.3. Sales Footprint
20.2.1.4. Analysis Commentary
20.2.2. F. Hoffmann-La Roche Ltd
20.2.3. Oxford Nanopore Technologies
20.2.4. Agilent Technologies
20.2.5. Thermo Fisher Scientific Inc
20.2.6. PerkinElmer, Inc.,
20.2.7. Becton, Dickinson and Company
20.2.8. QIAGEN N.V.
20.2.9. Pacific Biosciences of California, Inc.
20.2.10. BGI Group
20.2.11. Takara Bio, Inc
20.2.12. Creative-Biolabs
20.2.13. Mogene LC
21. Assumptions and Acronyms Used
22. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook